herxheimer reaction from iv glutathione Jarisch–Herxheimer Case 28-2023: A 37-Year-Old Man

With the monoclonal antibodies targeting amyloid, we got the first breakthrough. Biogen, the maker of aducanumab, later pulled it from the market to focus on a second drug, which is now one of two such antibodies available in the US

A board-based oxysterol screen in response to neuroinflammation revealed distinct patterns oxysterol production depending on the polarization of microglia (Mutemberezi et al., 2018)

The Effect of N-Acetylcysteine on the Treatment of Clinical Endometritis and Pregnancy Rate in Dairy Cows

Autophagy 18 , 19321954 (2022)

Here again, the free SH group of cysteine within glutathione confers functional properties to this molecule